Table 4.
Ordinal regression model analysis of influencing factors of PVWMH classifications.
| Predictor | PVWMH Fazekas grade | |||||
|---|---|---|---|---|---|---|
| Coefficient | Standard error | Z value | P-value | OR | 95%CI for OR | |
| Age | 0.085 | 0.010 | 73.770 | <0.01 | 1.089 | 1.067–1.110 |
| Hypertension | 0.479 | 0.193 | 6.143 | 0.013 | 1.614 | 1.105–2.358 |
| Diabetes mellitus | 0.457 | 0.195 | 5.502 | 0.019 | 1.579 | 1.078–2.314 |
| Atrial fibrillation | 0.214 | 0.503 | 0.181 | 0.671 | 1.239 | 0.462–3.320 |
| LI | 1.640 | 0.192 | 73.072 | <0.01 | 5.155 | 3.540–7.508 |
| LP-PLA2 <200* | −1.356 | 0.276 | 3.102 | 0.019 | 0.258 | 0.119–0.520 |
| LP-PLA2 200–223* | −1.187 | 0.421 | 7.949 | 0.005 | 0.305 | 0.134–0.696 |
| Cr | −0.003 | 0.004 | 0.408 | 0.523 | 0.997 | 0.989–1.006 |
| Hcy | 0.010 | 0.012 | 0.778 | 0.378 | 1.010 | 0.987–1.034 |
| H-CRP | −0.002 | 0.007 | 0.107 | 0.743 | 0.998 | 0.984–1.011 |
LI, lacunar infarction; Cr, creatinine; H-CRP, high C-reactive protein; Hcy, homocysteine; Lp-PLA2, lipoprotein-associated phospholipase A2;
*
LP-PLA2 >232.00 ug/L served as control.